Molecular Interaction Fields and 3D-QSAR Studies of p53-MDM2 Inhibitors Suggest Additional Features of Ligand-Target Interaction

被引:12
|
作者
Dezi, Cristina [1 ]
Carotti, Andrea [1 ]
Magnani, Matteo [2 ]
Baroni, Massimo [3 ]
Padova, Alessandro [2 ]
Cruciani, Gabriele [3 ,4 ]
Macchiarulo, Antonio [1 ]
Pellicciari, Roberto [1 ]
机构
[1] Univ Perugia, Dipartimento Chim & Tecnol Farmaco, I-06123 Perugia, Italy
[2] Siena Biotech SpA, I-53100 Siena, Italy
[3] Mol Discovery Ltd, Pinner HA55NE, Middx, England
[4] Univ Perugia, Dept Chem, Lab Chemometr & Cheminformat, I-06123 Perugia, Italy
关键词
STRUCTURE-BASED DESIGN; PROTEIN-PROTEIN INTERACTION; P53; PATHWAY; CONFORMATIONAL TRANSITIONS; MDMX INSIGHTS; BINDING; QSAR; OVEREXPRESSION; AMPLIFICATION; ANTAGONISTS;
D O I
10.1021/ci100113p
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The design and optimization of small molecule inhibitors of the murine double minute clone 2-p53 (p53-MDM) interaction has attracted a great deal of interest as a way to novel anticancer therapies. Herein we report 3D-QSAR studies of 41 small molecule inhibitors based on the use of molecular interaction fields and docking experiments as part of an approach to generating predictive models of MDM2 affinity and shedding further light on the structural elements of the ligand-target interaction. These studies have yielded predictive models explaining much of the variance of the 41 compound training set and satisfactorily predicting with 75% success an external test set of 36 compounds. Not surprisingly, and in full agreement with previous data, inspection of the 3D-QSAR coefficients reveals that the major driving force for potent inhibition is given by the hydrophobic interaction between the inhibitors and the p53 binding cleft of MDM2. More surprisingly, and challenging previous suggestions, the projection of the 3D-QSAR coefficients back onto the experimental structures of MDM2 provides an intriguing hypothesis concerning an active role played by the N-terminal region of MDM2 in ligand binding.
引用
收藏
页码:1451 / 1465
页数:15
相关论文
共 50 条
  • [1] QSAR: Hydropathic analysis of inhibitors of the p53-mdm2 interaction
    Galatin, PS
    Abraham, DJ
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2001, 45 (03) : 169 - 175
  • [2] The Docking Based 3D-QSAR Studies on Isoindolinone Derived Inhibitors of p53-MDM2 Binding
    Ying, Huazhou
    Wu, Chunlei
    Hu, Chunqi
    LETTERS IN DRUG DESIGN & DISCOVERY, 2014, 11 (01) : 50 - 58
  • [3] Small-Molecule Inhibitors of the p53-MDM2 Interaction
    Vu, Binh T.
    Vassilev, Lyubomir
    SMALL-MOLECULE INHIBITORS OF PROTEIN-PROTEIN INTERACTIONS, 2011, 348 : 151 - 172
  • [4] Patented small molecule inhibitors of p53-MDM2 interaction
    Deng, JX
    Dayam, R
    Neamati, N
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (02) : 165 - 188
  • [5] D-peptide inhibitors of the p53-MDM2 interaction for targeted molecular therapy of malignant neoplasms
    Liu, Min
    Li, Chong
    Pazgier, Marzena
    Li, Changqing
    Mao, Yubin
    Lv, Yifan
    Gu, Bing
    Wei, Gang
    Yuan, Weirong
    Zhan, Changyou
    Lu, Wei-Yue
    Lu, Wuyuan
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (32) : 14321 - 14326
  • [6] p53-Mdm2 Interaction Inhibitors as Novel Nongenotoxic Anticancer Agents
    Nayak, Surendra Kumar
    Khatik, Gopal L.
    Narang, Rakesh
    Monga, Vikramdeep
    Chopra, Harish Kumar
    CURRENT CANCER DRUG TARGETS, 2018, 18 (08) : 749 - 772
  • [7] Inhibiting the p53-MDM2 interaction:: An important target for cancer therapy
    Chène, P
    NATURE REVIEWS CANCER, 2003, 3 (02) : 102 - 109
  • [8] Patented inhibitors of p53-Mdm2 interaction (2006-2008)
    Weber, Lutz
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2010, 20 (02) : 179 - 191
  • [9] Synthesis and evaluation of novel orally active p53-MDM2 interaction inhibitors
    Miyazaki, Masaki
    Naito, Hiroyuki
    Sugimoto, Yuuichi
    Yoshida, Keisuke
    Kawato, Haruko
    Okayama, Tooru
    Shimizu, Hironari
    Miyazaki, Masaya
    Kitagawa, Mayumi
    Seki, Takahiko
    Fukutake, Setsuko
    Shiose, Yoshinobu
    Aonuma, Masashi
    Soga, Tsunehiko
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (14) : 4319 - 4331
  • [10] Design and synthesis of new inhibitors of p53-MDM2 interaction with a chalcone scaffold
    Pereira, Daniela
    Lima, Raquel T.
    Palmeira, Andreia
    Seca, Hugo
    Soares, Joana
    Gomes, Sara
    Raimundo, Liliana
    Maciel, Claudia
    Pinto, Madalena
    Sousa, Emilia
    Helena Vasconcelos, M.
    Saraiva, Lucilia
    Cidade, Honorina
    ARABIAN JOURNAL OF CHEMISTRY, 2019, 12 (08) : 4150 - 4161